These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 288353)

  • 1. The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity [proceedings].
    Svendsen O; Rasmussen F; Nielsen P; Steiness E
    Arch Toxicol Suppl; 1979; (2):409. PubMed ID: 288353
    [No Abstract]   [Full Text] [Related]  

  • 2. Local tissue damage after intramuscular injections in rabbits and pigs: quantitation by determination of creatine kinase activity at injection sites.
    Diness V
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):410-5. PubMed ID: 4036633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity.
    Svendsen O; Rasmussen F; Nielsen P; Steiness E
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):324-8. PubMed ID: 474142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute bioavailability of rabbit muscle creatine phosphokinase after intramuscular administration.
    Hsu H; Watanabe J
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):1922-8. PubMed ID: 6467475
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs.
    Steiness E; Rasmussen F; Svendsen O; Nielsen P
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):357-64. PubMed ID: 581031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle toxicity of diatrizoate and iohexol in rabbits. A model for local tissue damage.
    Thomsen HS; Golman K; Svendsen O
    Acta Radiol; 1991 Mar; 32(2):182-3. PubMed ID: 2031807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tests for local toxicity of intramuscular drug preparations. Comparison of in vivo and in vitro findings.
    Surber C; Dubach UC
    Arzneimittelforschung; 1989 Dec; 39(12):1586-9. PubMed ID: 2624610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for local toxicity of intramuscular drug preparations: comparison of in vivo and in vitro methods.
    Svendsen O; Højelse F; Bagdon RE
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):183-90. PubMed ID: 3993387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intramuscular injections on serum creatine phosphokinase activity.
    Meltzer HY; Mrozak S; Boyer M
    Am J Med Sci; 1970 Jan; 259(1):42-8. PubMed ID: 5416782
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal models.
    Sutton SC; Evans LA; Rinaldi MT; Norton KA
    Pharm Res; 1996 Oct; 13(10):1507-13. PubMed ID: 8899842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on elevation of serum creatine phosphokinase activity induced by exercise.
    Esaki K; Nakane K; Yamaji K; Suzuki Z; Hotta K
    Nagoya Med J; 1971 Nov; 17(1):41-7. PubMed ID: 5145834
    [No Abstract]   [Full Text] [Related]  

  • 12. Appraisal of the intramuscular irritation test in the rabbit.
    Gray JE
    Fundam Appl Toxicol; 1981; 1(3):290-2. PubMed ID: 7184795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of injection solution temperature on local muscle tissue damage in pigs.
    Svendsen O; Hansen HB; Jørgensen KD
    Pharmacol Toxicol; 1998 Jun; 82(6):301-3. PubMed ID: 9677622
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release.
    Lefebvre HP; Laroute V; Braun JP; Lassourd V; Toutain PL
    Vet Res; 1996; 27(4-5):343-61. PubMed ID: 8822606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local tolerance evaluation of intramuscular drug preparations.
    Cingolani E; Cingolani G; Mosconi P; Coppi G
    Farmaco Prat; 1986 Mar; 41(3):89-97. PubMed ID: 3709769
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal models.
    Sutton SC; Evans LA; Rinaldi MT; Norton KA
    Pharm Res; 1996 Oct; 13(10):1514-8. PubMed ID: 8899843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of multiple intramuscular placebo injections on injection-site tolerance and serum creatine phosphokinase activity.
    Vukovich RA
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):706-10. PubMed ID: 812648
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo non-invasive quantification of muscle damage following a single intramuscular injection of phenylbutazone in sheep.
    Houpert P; Serthelon JP; Lefebvre HP; Toutain PL; Braun JP
    Vet Hum Toxicol; 1995 Apr; 37(2):105-10. PubMed ID: 7631487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model.
    Evans LA; Genereux PE; Gibbs EM; Sutton SC
    Pharm Res; 1996 Oct; 13(10):1585-7. PubMed ID: 8899856
    [No Abstract]   [Full Text] [Related]  

  • 20. The rate of elimination and distribution volume of rabbit muscle creatine phosphokinase.
    Hsu H; Watanabe J
    Chem Pharm Bull (Tokyo); 1983 Feb; 31(2):626-31. PubMed ID: 6883590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.